Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcomaleiomyosarcoma of the corpus uteriActive, not recruitingPhase 22026-07-31NCT03880019

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Dana-Farber Cancer InstituteBostonUnited States626
Massachusetts General Hospital Cancer CenterBostonUnited States178
Mayo Clinic Hospital in ArizonaPhoenixUnited States120
Mayo Clinic in FloridaJacksonvilleUnited States224
Mayo Clinic in RochesterRochesterUnited States687
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer CenterNew YorkUnited States189
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
Stanford Cancer Institute Palo AltoPalo AltoUnited States122
UCHealth University of Colorado HospitalAuroraUnited States172
UF Health Cancer Institute - GainesvilleGainesvilleUnited States153
UPMC Hillman Cancer CenterPittsburghUnited States330
VCU Massey Comprehensive Cancer CenterRichmondUnited States273
Washington University School of MedicineSt LouisUnited States895
Wayne State University/Karmanos Cancer InstituteDetroitUnited States196
Weisberg Cancer Treatment CenterFarmington HillsUnited States135